Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate
NCT02789787 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117
Last updated 2021-10-11
Summary
Patients with cleft lip and palate frequently develop Class III (Cl III) malocclusions or underbites following early cleft repair surgeries. This clinical trial compares the current standard of care for treating the Cl III malocclusion, orthognathic (jaw) surgery after pubertal growth (16-21 years), with an alternative orthopedic approach to protract the maxilla during adolescence (11-14 years). At Children's Hospital Los Angeles(CHLA), early adolescents with cleft lip and palate and Cl III malocclusion are offered an alternative non-surgical approach to correct the malocclusion called "maxillary protraction". Prior to age 14, the maxillary sutures have not fused and can be mobilized by alternating weekly expansion and constriction with a rapid palatal expander (RPE), thereby allowing the upper jaw (maxilla) to be pulled forward (protracted) to correct the underbite. This prospective parallel cohort study will assess the patients undergoing treatment for the Cl III malocclusion by either orthognathic surgery or maxillary protraction at four data collection time points during treatment. The data includes digitized study models, photographs and radiographs, quality of life surveys (SF12, YQOL), parent surveys (ASEBA), treatment cost, periodontal measurements and treatment complications. The study design is a descriptive cohort study that examines the success of treatment (% not requiring a second surgery), the dental and skeletal changes associated with treatment, the stability of treatment and the behavioural/adaptive factors (ASEBA) that contribute to success and lack of success for each treatment. The primary trial will be conducted at Children's Hospital Los Angeles and a pilot study to confirm translation to different settings will be conducted at Seattle Children's Hospital.
Conditions
- Cleft Lip and Palate
Interventions
- PROCEDURE
-
Maxillary Protraction
"Maxillary protraction" is an alternative non-surgical approach to correct the Cl III malocclusion. At ages 11- 14, the maxillary sutures have not fused and can be mobilized by alternating weekly expansion and constriction with a rapid palatal expander (RPE), thereby allowing the maxilla to be protracted in order to correct the underbite. This treatment is offered to the patients, age 11-14, who have the Cl III malocclusion with or without cleft lip and palate.
- PROCEDURE
-
Orthognathic Surgery
The orthognathic surgery is the current standard of care for treating the Cl III malocclusion after pubertal growth. This treatment is offered to the patients, after pubertal growth, who have the Cl III malocclusion with or without cleft lip and palate.
Sponsors & Collaborators
-
Seattle Children's Hospital
collaborator OTHER -
Children's Hospital Los Angeles
collaborator OTHER -
University of Southern California
lead OTHER
Principal Investigators
-
Stephen Yen, DMD, PhD · CHLA
-
Jane Atkinson · National Institute of Dental and Craniofacial Research (NIDCR)
Eligibility
- Min Age
- 11 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-29
- Primary Completion
- 2021-05-31
- Completion
- 2021-05-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical Study to Investigate the Efficacy and Safety of NT 201 Compared to Placebo in the Treatment of Chronic Troublesome Drooling Associated With Neurological Disorders and/or Intellectual Disability
NCT02270736 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Study of Trofinetide for the Treatment of Girls Two to Five Years of Age Who Have Rett Syndrome
NCT04988867 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome
NCT07285005 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Topical Raplixa for Surgical Bleeding in Children
NCT02117349 ·Status: TERMINATED ·Phase: PHASE2
-
Prevention of Post Operative Bone Loss in Children
NCT00655681 ·Status: COMPLETED ·Phase: NA
-
Dexmedetomidine vs Placebo for Pediatric Cleft Palate Repair
NCT02915042 ·Status: WITHDRAWN ·Phase: PHASE4
-
Amicar Pharmacokinetics of Children Having Craniofacial Surgery
NCT00912119 ·Status: COMPLETED ·Phase: PHASE1
-
Treatment of the Cholesterol Defect in Smith-Lemli-Opitz Syndrome
NCT00272844 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
NCT00607542 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Efficacy of Amicar for Children Having Craniofacial Surgery
NCT02229968 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
NCT03813238 ·Status: COMPLETED ·Phase: PHASE3
-
Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy
NCT01386255 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy
NCT00294684 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Quetiapine for Pediatric Delirium
NCT02056171 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis
NCT01399047 ·Status: COMPLETED ·Phase: PHASE2
-
Open Label Trial of Triheptanoin (UX007) in Treatment of Rett Syndrome.
NCT03059160 ·Status: UNKNOWN ·Phase: PHASE2
-
Excessive Crying in Children With Cerebral Palsy and Communication Deficits
NCT04523935 ·Status: COMPLETED ·Phase: PHASE4
-
An Open Label, Exploratory Study to Investigate the Treatment Effect of Glatiramer Acetate on Girls Woth Rett Syndrome
NCT02023424 ·Status: UNKNOWN ·Phase: PHASE1
-
The Management of Postoperative Craniotomy Pain in Pediatric Patients
NCT01576601 ·Status: COMPLETED
-
Continued Anticonvulsants After Resolution of Neonatal Seizures: a Patient-centered Comparative Effectiveness Study
NCT02789176 ·Status: COMPLETED
-
RCT for Intermittent Versus Continuous Propofol Sedation for Pediatric Brain and Spine MRI Studies
NCT00515359 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Muscle Strength and Motor Ability in Children With Spinal Muscle Atrophy(SMA) Treated With Valproic Acid
NCT01033331 ·Status: COMPLETED
-
Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary Malformations
NCT02764411 ·Status: TERMINATED ·Phase: PHASE3
-
A Multi-site Feasibility Clinical Trial of Retraining and Control Therapy (ReACT), a Mind and Body Treatment for Pediatric Functional Seizures
NCT05819268 ·Status: RECRUITING ·Phase: NA
-
Erythropoietin Therapy for Children With Cerebral Palsy: Phase 1
NCT01586052 ·Status: COMPLETED ·Phase: PHASE1